StageZero Life Sciences Ltd Cash Flow-to-Debt Ratio
StageZero Life Sciences Ltd cash flow-to-debt ratio. StageZero Life Sciences Ltd (SZLS) has a Cash Flow-to-Debt Ratio of -0.01x as of September 2024, meaning its operating cash flow of CA$-145.57K could theoretically repay 0% of its total liabilities (CA$11.71 Million) in one year. Check StageZero Life Sciences Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of StageZero Life Sciences Ltd (1998–2022)
Cash flow-to-debt ratio of StageZero Life Sciences Ltd from 1998 to 2022. Historical debt coverage capacity for StageZero Life Sciences Ltd across 25 annual periods. Check how aggressively does StageZero Life Sciences Ltd reinvest cash to assess the company's total reinvestment commitment from operating cash flow.
StageZero Life Sciences Ltd Cash Flow-to-Debt Ratio by Year (1998–2022)
StageZero Life Sciences Ltd cash flow-to-debt ratio by year from 1998 to 2022. Year-by-year debt coverage analysis for StageZero Life Sciences Ltd. For the full cash flow conversion analysis, see SZLS cash generation efficiency.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2022 | -0.43x | CA$-3.53 Million | CA$8.20 Million | ▲ +62.1% |
| 2021 | -1.14x | CA$-8.95 Million | CA$7.88 Million | ▼ -261.0% |
| 2020 | -0.31x | CA$-3.06 Million | CA$9.74 Million | ▲ +55.8% |
| 2019 | -0.71x | CA$-4.59 Million | CA$6.46 Million | ▼ -58.2% |
| 2018 | -0.45x | CA$-3.29 Million | CA$7.32 Million | ▲ +32.9% |
| 2017 | -0.67x | CA$-3.82 Million | CA$5.71 Million | ▼ -48.6% |
| 2016 | -0.45x | CA$-3.68 Million | CA$8.17 Million | ▲ +38.8% |
| 2015 | -0.74x | CA$-1.73 Million | CA$2.34 Million | ▲ +62.8% |
| 2014 | -1.98x | CA$-1.54 Million | CA$776.12K | ▲ +43.0% |
| 2013 | -3.47x | CA$-4.34 Million | CA$1.25 Million | ▼ -324.1% |
| 2012 | -0.82x | CA$-4.06 Million | CA$4.97 Million | ▼ -27.0% |
| 2011 | -0.64x | CA$-2.83 Million | CA$4.39 Million | ▼ -28.3% |
| 2010 | -0.50x | CA$-2.46 Million | CA$4.91 Million | ▲ +57.9% |
| 2009 | -1.19x | CA$-4.61 Million | CA$3.87 Million | ▲ +32.4% |
| 2008 | -1.76x | CA$-7.51 Million | CA$4.26 Million | ▼ -10.9% |
| 2007 | -1.59x | CA$-8.31 Million | CA$5.22 Million | ▲ +57.8% |
| 2006 | -3.77x | CA$-6.23 Million | CA$1.65 Million | ▼ -923.8% |
| 2005 | -0.37x | CA$-1.05 Million | CA$2.85 Million | ▲ +19.1% |
| 2004 | -0.46x | CA$-2.48 Million | CA$5.46 Million | ▲ +47.9% |
| 2003 | -0.87x | CA$-469.80K | CA$537.81K | ▲ +56.9% |
| 2002 | -2.02x | CA$-707.49K | CA$349.42K | ▲ +68.9% |
| 2001 | -6.52x | CA$-1.04 Million | CA$160.17K | ▲ +71.7% |
| 2000 | -23.05x | CA$-1.86 Million | CA$80.63K | ▼ -167.4% |
| 1999 | -8.62x | CA$-29.87K | CA$3.47K | ▼ -392.0% |
| 1998 | -1.75x | CA$-5.00K | CA$2.86K | — |